Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocular Therapeutix (OCUL) EPS (Basic): 2013-2025

Historic EPS (Basic) for Ocular Therapeutix (OCUL) over the last 13 years, with Sep 2025 value amounting to -$0.38.

  • Ocular Therapeutix's EPS (Basic) fell 72.73% to -$0.38 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.43, marking a year-over-year decrease of 8.33%. This contributed to the annual value of -$1.22 for FY2024, which is 20.79% down from last year.
  • According to the latest figures from Q3 2025, Ocular Therapeutix's EPS (Basic) is -$0.38, which was up 2.56% from -$0.39 recorded in Q2 2025.
  • In the past 5 years, Ocular Therapeutix's EPS (Basic) registered a high of $0.04 during Q1 2021, and its lowest value of -$0.49 during Q1 2024.
  • Moreover, its 3-year median value for EPS (Basic) was -$0.35 (2023), whereas its average is -$0.31.
  • In the last 5 years, Ocular Therapeutix's EPS (Basic) soared by 115.79% in 2021 and then slumped by 2,100.00% in 2024.
  • Over the past 5 years, Ocular Therapeutix's EPS (Basic) (Quarterly) stood at -$0.05 in 2021, then tumbled by 300.00% to -$0.20 in 2022, then plummeted by 75.00% to -$0.35 in 2023, then increased by 20.00% to -$0.28 in 2024, then slumped by 72.73% to -$0.38 in 2025.
  • Its EPS (Basic) stands at -$0.38 for Q3 2025, versus -$0.39 for Q2 2025 and -$0.38 for Q1 2025.